Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ)
CNY 13.37
(0.91%)
CNY 13.37
(0.91%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 786.44 Million CNY | -49.84% |
| 2022 | 1.66 Billion CNY | 55.62% |
| 2021 | 1.06 Billion CNY | 16.34% |
| 2020 | 917.92 Million CNY | 24.18% |
| 2019 | 739.21 Million CNY | 8.02% |
| 2018 | 684.32 Million CNY | -0.44% |
| 2017 | 687.38 Million CNY | 75.09% |
| 2016 | 392.57 Million CNY | 3.58% |
| 2015 | 379.01 Million CNY | 10.04% |
| 2014 | 344.42 Million CNY | 30.3% |
| 2013 | 264.34 Million CNY | 32.91% |
| 2012 | 198.88 Million CNY | 27.23% |
| 2011 | 156.32 Million CNY | 26.12% |
| 2010 | 123.94 Million CNY | 12.9% |
| 2009 | 109.77 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 58.68 Million CNY | -21.42% |
| 2024 Q1 | 296.33 Million CNY | 21038.74% |
| 2024 Q2 | 74.69 Million CNY | -74.79% |
| 2023 Q4 | 1.4 Million CNY | -99.35% |
| 2023 Q1 | 279.08 Million CNY | -43.77% |
| 2023 Q2 | 291.61 Million CNY | 4.49% |
| 2023 FY | 833.53 Million CNY | -49.84% |
| 2023 Q3 | 215.79 Million CNY | -26.0% |
| 2022 Q1 | 202.44 Million CNY | -3.69% |
| 2022 FY | 1.66 Billion CNY | 55.62% |
| 2022 Q4 | 496.34 Million CNY | 70.33% |
| 2022 Q3 | 291.4 Million CNY | 15.39% |
| 2022 Q2 | 252.53 Million CNY | 24.74% |
| 2021 FY | 1.06 Billion CNY | 16.34% |
| 2021 Q4 | 210.19 Million CNY | -21.93% |
| 2021 Q3 | 269.23 Million CNY | -11.69% |
| 2021 Q2 | 304.88 Million CNY | 7.49% |
| 2021 Q1 | 283.62 Million CNY | 64.27% |
| 2020 Q3 | 239.69 Million CNY | -8.36% |
| 2020 FY | 917.92 Million CNY | 24.18% |
| 2020 Q1 | 244.01 Million CNY | 60.87% |
| 2020 Q2 | 261.56 Million CNY | 7.19% |
| 2020 Q4 | 172.65 Million CNY | -27.97% |
| 2019 Q4 | 151.68 Million CNY | -15.15% |
| 2019 FY | 739.21 Million CNY | 8.02% |
| 2019 Q3 | 178.76 Million CNY | -9.01% |
| 2019 Q2 | 196.46 Million CNY | -7.46% |
| 2019 Q1 | 212.29 Million CNY | 30.48% |
| 2018 Q2 | 199.83 Million CNY | 25.24% |
| 2018 Q1 | 159.56 Million CNY | -1.42% |
| 2018 FY | 684.32 Million CNY | -0.44% |
| 2018 Q4 | 162.7 Million CNY | 0.29% |
| 2018 Q3 | 162.22 Million CNY | -18.82% |
| 2017 Q2 | 129.79 Million CNY | 16.73% |
| 2017 Q1 | 111.18 Million CNY | 33.49% |
| 2017 FY | 687.38 Million CNY | 75.09% |
| 2017 Q4 | 161.86 Million CNY | 54.78% |
| 2017 Q3 | 104.57 Million CNY | -19.43% |
| 2016 Q1 | 113.79 Million CNY | 11.52% |
| 2016 Q2 | 104.25 Million CNY | -8.38% |
| 2016 FY | 392.57 Million CNY | 3.58% |
| 2016 Q3 | 91.23 Million CNY | -12.5% |
| 2016 Q4 | 83.29 Million CNY | -8.7% |
| 2015 Q4 | 102.04 Million CNY | 21.39% |
| 2015 FY | 379.01 Million CNY | 10.04% |
| 2015 Q2 | 92.51 Million CNY | -7.85% |
| 2015 Q1 | 100.39 Million CNY | 1.12% |
| 2015 Q3 | 84.06 Million CNY | -9.13% |
| 2014 Q2 | 90.3 Million CNY | 5.39% |
| 2014 FY | 344.42 Million CNY | 30.3% |
| 2014 Q4 | 99.27 Million CNY | 43.54% |
| 2014 Q3 | 69.16 Million CNY | -23.41% |
| 2014 Q1 | 85.68 Million CNY | 16.56% |
| 2013 Q4 | 73.51 Million CNY | 21.2% |
| 2013 FY | 264.34 Million CNY | 32.91% |
| 2013 Q2 | 59.07 Million CNY | -16.93% |
| 2013 Q3 | 60.65 Million CNY | 2.68% |
| 2013 Q1 | 71.1 Million CNY | 0.0% |
| 2012 FY | 198.88 Million CNY | 27.23% |
| 2011 FY | 156.32 Million CNY | 26.12% |
| 2010 FY | 123.94 Million CNY | 12.9% |
| 2009 FY | 109.77 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 733.77 Million CNY | -7.178% |
| ZJAMP Group Co., Ltd. | 1.05 Billion CNY | 25.189% |
| Luyan Pharma Co.,Ltd. | 468.55 Million CNY | -67.844% |
| Ji Yao Holding Group Co., Ltd. | -346.79 Million CNY | 326.777% |